The FDA just approved the first coronavirus drug - but this new medicine might be even better

Researchers tested a cancer drug called plitidepsin as a coronavirus therapy and discovered it can block the virus's ability to replicate. The use of plitidepsin reduced viral loads after just seven days and improved blood test markers for inflammation. Nearly 40% of a limited group of patients who received various doses of plitidepsin were discharged after just eight days in the hospital. Doctors looking to devise therapies that can cure patients infected with the novel coronavirus have tried a...